相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing
Jeff Chang et al.
GASTROENTEROLOGY (2017)
Study of the mechanisms of a Japanese traditional fermented medicine in the improvement of constipation
Tadashi Shimoyama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy
Daniel Kotlarz et al.
GASTROENTEROLOGY (2012)
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The role of bacteria and pattern-recognition receptors in Crohn's disease
Si Ming Man et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
Fernando Magro et al.
BIODRUGS (2010)
Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats
Tomoko Maeda et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease
Stefano Guandalini
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Clinical significance of serum diamine oxidase activity in inflammatory bowel disease
Yusuke Honzawa et al.
INFLAMMATORY BOWEL DISEASES (2010)
Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience
Ian C. Lawrance et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Probiotics promote gut health through stimulation of epithelial innate immunity
Cristiano Pagnini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Neutrophil Infiltration and Oxidative Stress May Play a Critical Role in Methotrexate-Induced Renal Damage
Viswa Kalyan Kolli et al.
CHEMOTHERAPY (2009)
388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study
Antonio Tursi et al.
GASTROENTEROLOGY (2009)
Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease
C. Reiff et al.
INFLAMMATORY BOWEL DISEASES (2009)
IL-1β Augments TNF-α-Mediated Inflammatory Responses from Lung Epithelial Cells
Sara Saperstein et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Erik-Oliver Glocker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
Frank Hoentjen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2
M. Schlee et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Potent protective effect of apricot and beta-carotene on methotrexate-induced intestinal oxidative damage in rats
Nigar Vardi et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Treatment of inflammatory bowel disease: A review of medical therapy
Patricia L. Kozuch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor at agents
Andrew Nesbitt et al.
INFLAMMATORY BOWEL DISEASES (2007)
Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
Arthur Barrie et al.
INFLAMMATORY BOWEL DISEASES (2007)
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials
Charlotte Hedin et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2007)
Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications
Joachim Mankertz et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
C. Caballero-Franco et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
A traditional Japanese medicine mitigates TNBS-induced colitis in rats
Yoshihiro Fukuda et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency
Peter J. Mannon et al.
GASTROENTEROLOGY (2006)
The gastrointestinal tract stem cell niche
Tzung-Hai Yen et al.
STEM CELL REVIEWS (2006)
Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice
B Shen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Biologic therapy for inflammatory bowel disease
S Ardizzone et al.
DRUGS (2005)
Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis
BA Carneiro et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats
Y Miyazono et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
The relationship between the concentration of dextran sodium sulfate and the degree of induced experimental colitis in weanling rats
T Shimizu et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2003)
Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic damage and regeneration
M Verburg et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Variable response to problotics in two models of experimental colitis in rats
O Shibolet et al.
INFLAMMATORY BOWEL DISEASES (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
The expression of IL-12 p40 and its homologue Epstien-Barr virus-induced gene 3, in inflammatory bowel disease
F Omata et al.
INFLAMMATORY BOWEL DISEASES (2001)
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
P Gionchetti et al.
GASTROENTEROLOGY (2000)
Therapy of inflammatory bowel disease
BE Sands
GASTROENTEROLOGY (2000)